Headache: Phase III trials

Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine

Ubrogepant

Phase III

Migraine

United States

Ongoing, not yet recruiting

https://clinicaltrials.gov/ct2/show/NCT02867709?term=headache&rcv_s=07%2F25%2F2016&rcv_e=08%2F25%2F2016&lup_s=07%2F25%2F2016&lup_e=08%2F25%2F2016&rank=9&submit_fld_opt=


An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine

Ubrogepant

Phase III

United States

Ongoing, not yet recruiting

Click here for further information


Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine

Ubrogepant

Phase III

United States

Ongoing, not yet recruiting

Click here for further information


Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral AGN-241689 in Episodic Migraine Prevention

AGN-241689

Phase III

United States

Ongoing, not yet recruiting

Click here for further information


An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine

Ubrogepant

Phase III

United States

Ongoing, not yet recruiting

Click here for further information


A Study of LY2951742 in Participants With Episodic Cluster Headache

LY2951742

Phase III

Multiple worldwide locations

Recruiting

Click here for further information